{
  "meta": {
    "title": "Management_Of_Glaucoma",
    "url": "https://brainandscalpel.vercel.app/management-of-glaucoma-41399887.html",
    "scrapedAt": "2025-11-29T18:31:15.863Z"
  },
  "questions": [
    {
      "id": 15197,
      "choices": [
        {
          "id": 60748,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Purulent Conjunctivitis</span></span></span></span></p>"
        },
        {
          "id": 60749,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Immature Cataract</span></span></span></span></p>"
        },
        {
          "id": 60750,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Glaucoma</span></span></span></span></p>"
        },
        {
          "id": 60751,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">R<span style=\"color:black\">etinal Detachment</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Coloured halos are seen in all of </span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">the following<span style=\"color:black\"> except?</span></span></span></span></p>",
      "unique_key": "Q3228995",
      "question_audio": null,
      "question_video": null,
      "map_id": 31282,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Retinal Detachment </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coloured Halos are seen in <strong>Purulent Conjunctivitis</strong>, <strong>Cataract</strong> and <strong>Glaucoma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-122636.jpg\" style=\"height:188px; width:1000px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Purulent Conjunctivitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ndash;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Immature Cataract</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - As a cataract develops, <strong>changes</strong> in the <strong>lens</strong> can <strong>scatter light</strong>, <strong>leading</strong> to the <strong>perception</strong> of <strong>colored halos</strong> around <strong>lights</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glaucoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - <strong>Acute angle-closure glaucoma</strong> can lead to the <strong>sudden onset</strong> of <strong>visual disturbances</strong>, including seeing <strong>colored halos</strong> around <strong>lights</strong> due to <strong>corneal edema</strong> caused by the <strong>elevated intraocular pressure</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize that <strong>colored halos</strong> are visual phenomena associated with <strong>corneal edema</strong> or <strong>lens changes</strong>, as seen in <strong>glaucoma</strong> and <strong>immature cataract</strong>, but not typically with retinal detachment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Comprehensive Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 243</span></strong></span></span></p>",
      "correct_choice_id": 60751,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15236,
      "choices": [
        {
          "id": 60904,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Adjunctive Anti-Metabolites enhance the natural healing response at the site of filtration surgery.</span></span></span></span></p>"
        },
        {
          "id": 60905,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Can be used intraoperatively.</span></span></span></span></p>"
        },
        {
          "id": 60906,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Helps in bleb maintenance</span></span></span></span></p>"
        },
        {
          "id": 60907,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Placed under the tenon&rsquo;s capsule for 2 minutes.</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Which of the following is false regarding use of anti-metabolites in filtration surgery? </span></span></span></span></p>",
      "unique_key": "Q3845938",
      "question_audio": null,
      "question_video": null,
      "map_id": 31274,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ans. A) Adjunctive Anti-Metabolites enhance the natural healing response at the site of filtration surgery.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Adjunctive antimetabolites <strong>INHIBIT</strong> the <strong>natural healing response</strong> at the <strong>site</strong> of <strong>filtration surgery</strong> that may <strong>preclude</strong> <strong>successful filtration surgery</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Helps in <strong>bleb formation</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">E.g. 5-fluorouracil, Mitomycin C </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option B.&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">This is <strong>true</strong>. <strong>Antimetabolites</strong> are often applied during <strong>filtration surgery</strong>. They can be <strong>applied</strong> to the <strong>surgical site</strong> for a <strong>brief period</strong>, usually a few minutes, to <strong>reduce postoperative scarring</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option C.&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">This is <strong>true</strong>. By <strong>inhibiting fibrosis</strong> and <strong>scarring</strong>, <strong>antimetabolites</strong> help in <strong>maintaining</strong> the <strong>function</strong> of the <strong>bleb</strong>, which is <strong>crucial</strong> for the <strong>success</strong> of <strong>filtration surgery</strong> in <strong>lowering intraocular pressure</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">. This is generally <strong>true</strong>. The <strong>application</strong> of <strong>antimetabolites</strong> like <strong>MMC</strong> is often performed by <strong>placing</strong> a <strong>sponge soaked</strong> with the <strong>drug</strong> under the <strong>Tenon&rsquo;s capsule</strong> for a <strong>limited time</strong>, commonly <strong>around 2</strong> to <strong>5 minutes</strong>, depending on the <strong>concentration </strong>of the <strong>drug</strong> and the <strong>surgeon&rsquo;s preference</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Educational Objective</span></span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">: </span></span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Adjunctive anti metabolites&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">are used in <strong>filtration surgery</strong>, such as <strong>trabeculectomy</strong> for <strong>inhibiting</strong>, not enhancing, the <strong>natural healing response</strong> at the <strong>surgical site</strong>. These agents are used <strong>intraoperatively</strong> to <strong>prevent postoperative scarring</strong> and <strong>fibrosis</strong>, thereby <strong>aiding</strong> in the <strong>maintenance</strong> of the <strong>bleb</strong>, essential for the <strong>surgery&#39;s success</strong>. Antimetabolites are typically <strong>applied</strong> under the <strong>Tenon&rsquo;s capsule</strong> for a <strong>brief duration</strong> during the <strong>procedure</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ref</span></span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">:&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Kanski&rsquo;s&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical Ophthalmology, 8<sup>th</sup> Edition, Page 339, 340</span></strong></span></span></p>",
      "correct_choice_id": 60904,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15242,
      "choices": [
        {
          "id": 60928,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Pan Retinal Photocoagulation</span></span></span></span></p>"
        },
        {
          "id": 60929,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Cyclo-Cryotherapy</span></span></span></span></p>"
        },
        {
          "id": 60930,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Peripheral Iridectomy</span></span></span></span></p>"
        },
        {
          "id": 60931,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Goniotomy </span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Identify the procedure shown.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture38.jpg\" style=\"height:186px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q1989678",
      "question_audio": null,
      "question_video": null,
      "map_id": 31278,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Ans. B) Cyclo-Cryotherapy </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#212121\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cyclodestruction procedures aim to <strong>decrease intraocular pressure (IOP)</strong> by <strong>decreasing&nbsp;&nbsp; production</strong> of <strong>aqueous humor</strong> by the <strong>ciliary body</strong> (specifically the <strong>ciliary processes</strong>). </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Done for <strong>absolute glaucoma</strong>.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Pan Retinal Photocoagulation&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is a <strong>laser treatment</strong> used <strong>primarily</strong> in the <strong>management</strong> of <strong>diabetic retinopathy</strong> and other retinal conditions. It involves <strong>applying laser burns</strong> to the <strong>retina</strong>, especially the <strong>peripheral areas</strong>, to <strong>reduce oxygen</strong> <strong>demand</strong> and <strong>prevent further retinal damage</strong>. It does not involve the ciliary body or the use of a cryoprobe.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C. Peripheral Iridectomy&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is surgical procedure that involves the <strong>removal</strong> of a <strong>small portion</strong> of the <strong>peripheral iris</strong>. It&#39;s commonly used in the <strong>treatment</strong> of <strong>angle-closure glaucoma</strong> to create an <strong>alternative pathway</strong> for <strong>aqueous humor</strong> to <strong>flow</strong> from the <strong>posterior</strong> to the <strong>anterior chamber</strong>, thus <strong>relieving pupillary block</strong>.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">. <strong>Goniotomy&nbsp;</strong>is a <strong>surgical procedure</strong> used <strong>primarily</strong> in the <strong>treatment</strong> of <strong>congenital glaucoma</strong>. It involves <strong>making</strong> an <strong>incision</strong> in the <strong>trabecular meshwork</strong>, the <strong>eye&#39;s drainage system</strong>, to <strong>improve</strong> the <strong>outflow</strong> of <strong>aqueous humor</strong> and <strong>lower intraocular pressure</strong>.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective</span></span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">:</span></span></u></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cyclo-cryotherapy&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is the <strong>ophthalmic procedure</strong> where a <strong>cryoprobe</strong> is applied to the <strong>ciliary body</strong>. It is typically used in the <strong>management</strong> of <strong>advanced</strong> or <strong>refractory glaucoma</strong> cases to <strong>decrease aqueous humor production</strong>.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref:&nbsp;</span></span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Comprehensive&nbsp;</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ophthalmology, A K Khurana, 5<sup>th</sup> Edition, Page 219</span></span></strong></p>",
      "correct_choice_id": 60929,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15271,
      "choices": [
        {
          "id": 61044,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyclosporin</span></span></span></p>"
        },
        {
          "id": 61045,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitomycin C </span></span></span></p>"
        },
        {
          "id": 61046,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tacrolimus </span></span></span></p>"
        },
        {
          "id": 61047,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riboflavin </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with a failed trabeculectomy was taken up for re-surgery. Which of the following adjuvants is preferred to reduce recurrence?</span></span></p>",
      "unique_key": "Q6509707",
      "question_audio": null,
      "question_video": null,
      "map_id": 31276,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Mitomycin C </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antimetabolites are agents used in various <strong>ocular surgeries</strong> to <strong>prevent fibroblastic response</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>agents</strong> commonly used include: </span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-Fluorouracil (5-FU)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitomycin C(MMC)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5-FU - 50 mg/ml it can be placed under the <strong>conjunctiva intraoperatively</strong> or <strong>administered</strong> as <strong>subconjunctival injections</strong> of <strong>5 mg/ml daily</strong> or on <strong>alternate days</strong>, up to a <strong>total dose</strong> of <strong>50 mg</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical drops&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>0.2&ndash;0.4 mg/ml of MMC</strong> have been used <strong>daily</strong> after <strong>pterygium surgery</strong> to <strong>reduce scarring</strong> and <strong>recurrences</strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A sponge soaked&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">in <strong>0.2&ndash;0.4 mg/ml of MMC</strong> is placed <strong>subconjunctivally</strong> or <strong>between</strong> the <strong>two scleral layers</strong> during <strong>surgery</strong> for a <strong>duration</strong> of <strong>1&ndash;3 minutes</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Cyclosporin:</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Immunosuppressant</strong>. <strong>Calcineurin inhibitor</strong>; <strong>binds cyclophilin</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Tacrolimus:</strong>&nbsp;<strong>Immunosuppressant</strong>. <strong>Calcineurin inhibitor</strong>; <strong>binds FK506 binding protein</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Riboflavin:</strong>&nbsp;<strong>Vitamin B2</strong>. <strong>Deficiency</strong> causes <strong>corneal revascularization</strong>, <strong>cheilosis</strong>, <strong>magenta tongue</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antimetabolites&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">used for as <strong>adjuvants</strong> in <strong>trabeculectomy</strong> are <strong>5-Fluorouracil</strong> and <strong>Mitomycin-C</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parsons Diseases of Eye 22<sup>nd</sup> Edition Page:160</span></span></strong></p>",
      "correct_choice_id": 61045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15274,
      "choices": [
        {
          "id": 61056,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brinzolamide </span></span></span></p>"
        },
        {
          "id": 61057,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide </span></span></span></p>"
        },
        {
          "id": 61058,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dichlorphenamide </span></span></span></p>"
        },
        {
          "id": 61059,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methazolamide </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following carbonic anhydrase inhibitors is used topically in glaucoma treatment? </span></span></p>",
      "unique_key": "Q7062463",
      "question_audio": null,
      "question_video": null,
      "map_id": 31277,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Brinzolamide</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbonic Anhydrase inhibitors block&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">the action of <strong>Carbonic Anhydrase</strong> and <strong>reduce</strong> the <strong>production</strong> of <strong>Aqueous</strong> in the <strong>eye</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Topical Preparations:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2% Dorzolamide </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1% Brinzolamide </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral Preparations&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>Carbonic Anhydrase Inhibitors</strong> are: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetazolamide </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dichlorphenamide </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methazolamide </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brinzolamide&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">and <strong>Dorzolamide</strong> the topical preparations of <strong>Carbonic Anhydrase Inhibitors</strong> used to <strong>reduce intraocular pressure</strong> in <strong>Glaucoma</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Parsons Diseases of Eye 22<sup>nd</sup> Edition Page: 157</span></span></strong></p>",
      "correct_choice_id": 61056,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15291,
      "choices": [
        {
          "id": 61124,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ketamine</span></span></span></span></p>"
        },
        {
          "id": 61125,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Morphine</span></span></span></span></p>"
        },
        {
          "id": 61126,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Diazepam</span></span></span></span></p>"
        },
        {
          "id": 61127,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fentanyl</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A surgeon </span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">noticed an increase<span style=\"color:black\"> in </span>Intraocular<span style=\"color:black\"> pressure after inducing Anesthesia. What could be the possible drug used?</span></span></span></p>",
      "unique_key": "Q5957962",
      "question_audio": null,
      "question_video": null,
      "map_id": 31281,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ans. A)&nbsp;</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketamine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ketamine, a <strong>dissociative anesthetic</strong>, is known to <strong>increase intraocular pressure</strong>. It stimulates the <strong>central nervous system</strong> and can cause an <strong>increase</strong> in <strong>sympathetic tone</strong>, leading to <strong>elevated IOP</strong>. This makes it less desirable for use in patients with <strong>glaucoma</strong> or other conditions where <strong>increased IOP</strong> is a <strong>concern</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Anesthetic Drugs</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong>affecting</strong> </span></span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">intra-ocular <span style=\"color:black\">pressure</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/screenshot-2024-02-02-153414.jpg\" style=\"height:330px; width:1000px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\"><strong>Option B.</strong>&nbsp;</span></span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong>Opioids</strong> like morphine typically <strong>do not</strong> significantly <strong>affect intraocular pressure</strong>. In fact, some opioids can <strong>decrease IOP</strong>, although this is <strong>not</strong> a <strong>primary effect</strong> and may <strong>not be</strong> <strong>clinically significant</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option C.&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Diazepam, a <strong>benzodiazepine</strong>, generally <strong>does not</strong> significantly <strong>increase intraocular pressure</strong>. It is often used in <strong>anesthesia</strong> for its <strong>sedative</strong> and <strong>anxiolytic effects</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D.&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Fentanyl, another <strong>opioid</strong>, is <strong>similar</strong> to <strong>morphine</strong> in that it <strong>does not</strong> typically <strong>increase intraocular pressure</strong>. In fact, it may <strong>slightly decrease IOP</strong>, but like <strong>morphine</strong>, this effect is not usually significant in the clinical setting.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Among the given options, <strong>ketamine</strong> is known to <strong>increase intraocular pressure</strong>, making it a <strong>less preferable choice</strong> in patients where <strong>elevated IOP</strong> is a <strong>concern</strong>, such as those with <strong>glaucoma</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: P</span></span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">g 94/Anatomy and Physiology of Eye/AK KHURANA/3<sup>rd</sup> Edition</span></span></strong></span></span></p>",
      "correct_choice_id": 61124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15327,
      "choices": [
        {
          "id": 61268,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Aqueous Humour</span></span></span></span></p>"
        },
        {
          "id": 61269,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Blood Plasma</span></span></span></span></p>"
        },
        {
          "id": 61270,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Vitreous Humour</span></span></span></span></p>"
        },
        {
          "id": 61271,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Cornea </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Mannitol is a Hyperosmotic Agent used to Lower Intraocular Pressure. Where does it draw water from?</span></span></span></span></p>",
      "unique_key": "Q2386691",
      "question_audio": null,
      "question_video": null,
      "map_id": 31283,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Vitreous Humour</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Hyperosmotic agents like mannitol penetrate the eye <strong>poorly</strong> because of the <strong>blood ocular barrier</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Mannitol &lsquo;draws-out&rsquo; water&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">from <strong>vitreous</strong> into the <strong>blood</strong> by creating an <strong>osmotic gradient</strong> and causes a <strong>reduction</strong> in <strong>intraocular pressure</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is to be <strong>avoided</strong> in patients with <strong>cardiac</strong> and <strong>renal disease</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aqueous Humour<strong>:</strong> While mannitol does affect the aqueous humour, its primary action isn&#39;t directly drawing water from the aqueous humour. The <strong>reduction</strong> in <strong>intraocular pressure</strong> following <strong>mannitol administration</strong> is more a result of the <strong>overall decrease</strong> in <strong>vascular volume</strong> within the eye.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blood plasma<strong>:</strong> Mannitol works by creating an <strong>osmotic gradient</strong> between the <strong>blood plasma</strong> and <strong>ocular tissues</strong>. It is <strong>administered intravenously</strong> and <strong>increases</strong> the <strong>osmolality</strong> of the <strong>blood plasma</strong>. However, mannitol does not draw water from the blood plasma; rather, it draws <strong>water</strong> into the <strong>blood plasma</strong> from <strong>surrounding tissues</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cornea: While the <strong>cornea</strong> does contain <strong>water</strong>, <strong>mannitol&#39;s</strong> primary <strong>action</strong> in <strong>reducing intraocular pressure</strong> is <strong>not focused</strong> on <strong>drawing water</strong> directly from the <strong>cornea</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mannitol</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, a <strong>hyperosmotic agent</strong>, <strong>reduces intraocular pressure</strong> by <strong>drawing water</strong> from the <strong>vitreous humour</strong> into the <strong>blood plasma</strong>, thereby <strong>decreasing</strong> the <strong>volume</strong> of <strong>ocular fluids</strong> and the <strong>intraocular pressure</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pg 79/ Anatomy &amp; Physiology of Eye /3<sup>rd</sup> edition/ AK KHURANA; Pg 407/ Ch. 11 Glaucoma/ 9<sup>th</sup> Edition/ Kanski&rsquo;s Clinical Ophthalmology</span></strong></span></span></p>",
      "correct_choice_id": 61270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18509,
      "choices": [
        {
          "id": 73994,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Rimexolone</span></span></span></span></p>"
        },
        {
          "id": 73995,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Tropicamide </span></span></span></span></p>"
        },
        {
          "id": 73996,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Pilocarpine</span></span></span></p>"
        },
        {
          "id": 73997,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Latanoprost </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old hypermetropic patient with a shallow anterior chamber came for an ophthalmic consultation. Post administration of a drug in the right eye, the patient developed pain and redness in the right eye associated with headache. The drug inducing this would be?</span></span></span></p>",
      "unique_key": "Q2125408",
      "question_audio": null,
      "question_video": null,
      "map_id": 31279,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Tropicamide </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a <strong>hypermetropic patient</strong> with <strong>shallow anterior chamber</strong>, use of <strong>cycloplegics</strong> result in <strong>mydriasis</strong> resulting in <strong>crowding</strong> of the <strong>angle</strong> &ndash; this results in <strong>acute angle closure attack.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. Rimexolone is a <strong>corticosteroid</strong> used in <strong>ophthalmology</strong> primarily for its <strong>anti-inflammatory effects</strong>. Steroids like rimexolone can <strong>increase intraocular pressure</strong>, particularly in individuals <strong>predisposed</strong> to <strong>open-angle glaucoma</strong>, but they are not typically associated with causing angle-closure glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilocarpine</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>miotic</strong> <strong>agent</strong> that <strong>constricts</strong> the <strong>pupil</strong>. Pilocarpine is actually used in the <strong>treatment</strong> of <strong>angle-closure glaucoma</strong> because it pulls the <strong>iris away</strong> from the <strong>trabecular meshwork</strong>, opening the <strong>anterior chamber angle</strong> and <strong>facilitating</strong> <strong>aqueous humor outflow</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latanoprost</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a <strong>prostaglandin analogue</strong> used to <strong>lower intraocular pressure</strong> in <strong>open-angle glaucoma</strong> and <strong>ocular hypertension</strong>. It is not known to cause angle-closure glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tropicamide</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, a <strong>mydriatic agent</strong> that <strong>dilates</strong> the <strong>pupil</strong>, can <strong>precipitate angle-closure glaucoma</strong> in susceptible individuals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PARSONS DISEASES OF EYE 22<sup>ND</sup> EDITION PAGE 155</span></span></strong></p>",
      "correct_choice_id": 73995,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18515,
      "choices": [
        {
          "id": 74018,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Olopatadine </span></span></span></span></p>"
        },
        {
          "id": 74019,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Epinephrine </span></span></span></span></p>"
        },
        {
          "id": 74020,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Latanoprost </span></span></span></span></p>"
        },
        {
          "id": 74021,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Apraclonidine </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which drug is responsible for the presentation given below?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/02/02/picture49.jpg\" style=\"height:129px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q4306719",
      "question_audio": null,
      "question_video": null,
      "map_id": 31280,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Latanoprost</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">The picture shows <strong>hyperpigmentation&nbsp;</strong>of <strong>iris</strong> and <strong>periocular skin</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Irreversible</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"> <strong>iris hyperpigmentation&nbsp;</strong>is noted in patient with <strong>topical use</strong> of <strong>prostaglandin analogues</strong>.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is caused by an <strong>increase</strong> in the <strong>number of pigmented granules</strong> within the <strong>superficial stroma</strong> rather than an <strong>increase</strong> in the <strong>number of melanocytes</strong>. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A. Olopatadine&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is an <strong>antihistamine</strong> used primarily for the <strong>treatment</strong> of <strong>allergic conjunctivitis</strong>. Olopatadine is not commonly associated with iris hyperpigmentation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option B.&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Epinephrine (adrenaline) is not typically associated with causing iris <strong>hyperpigmentation</strong>. Its <strong>primary ocular effects</strong> are related to its <strong>sympathomimetic activity</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option D. Apraclonidine&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is an <strong>alpha agonist</strong> used to <strong>reduce intraocular pressure</strong> in <strong>glaucoma</strong>. Apraclonidine is not known to cause iris hyperpigmentation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective</span></span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: </span></span></u></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Latanoprost</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">, a <strong>prostaglandin analogue</strong> used in the <strong>treatment of glaucoma</strong> and <strong>ocular hypertension</strong>, is associated with <strong>causing iris hyperpigmentation</strong> by <strong>increasing melanin production</strong> in the <strong>stromal melanocytes</strong> of the <strong>iris</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: KANSKI 9<sup>TH</sup> EDITION PAGE 404</span></strong></span></span></p>",
      "correct_choice_id": 74020,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18531,
      "choices": [
        {
          "id": 74082,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Degraded by Corneal Protease</span></span></span></span></p>"
        },
        {
          "id": 74083,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">NO &ndash; Donating PG Analogue</span></span></span></span></p>"
        },
        {
          "id": 74084,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increases Uveoscleral Outflow</span></span></span></span></p>"
        },
        {
          "id": 74085,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increases Trabecular Outflow</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the following statements are true about latanoprostenebunod except which one?</span></span></p>",
      "unique_key": "Q6259976",
      "question_audio": null,
      "question_video": null,
      "map_id": 31273,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) D<span style=\"color:black\">egraded by Corneal Protease.</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Option A:&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Upon <strong>topical administration</strong>, <strong>LBN</strong> is <strong>hydrolysed</strong> by <strong>endogenous corneal esterases</strong> into <strong>latanoprost acid</strong> and <strong>butanediol mononitrate</strong>, which is further metabolized to NO and the <strong>inactive 1, 4-butanediol</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>NO &ndash; donating PG analogue</strong>: Latanoprostenebunod is a <strong>Nitric Oxide (NO)-</strong>donating <strong>prostaglandin F2&alpha; analogue</strong>. Its unique feature is that it <strong>releases nitric oxide</strong> upon <strong>hydrolysis</strong>, which contributes to its <strong>intraocular pressure-lowering effects</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.&nbsp;<strong>Increases uveoscleral outflow</strong>: The primary mechanism of action of <strong>prostaglandin analogues</strong>, like latanoprostenebunod, is to <strong>increase uveoscleral outflow</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases Trabecular Outflow: The <strong>NO-donating aspect</strong> of this drug <strong>mediates increase</strong> in <strong>Trabecular Outflow</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AAO SECTION: 2 &ndash; 2020 EDITION PAGE 395; Hoy SM. LatanoprosteneBunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension. Drugs. 2018 May; 78(7):773-780. doi: 10.1007/s40265-018-0914-6. Erratum in: Drugs. 2018 Jun; 78(8):857. PMID: 29761382; PMCID: PMC5976683</span></span></strong></p>",
      "correct_choice_id": 74082,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18533,
      "choices": [
        {
          "id": 74090,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increases Trabecular Outflow</span></span></span></span></p>"
        },
        {
          "id": 74091,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Decreases Episcleral Venous Pressure</span></span></span></span></p>"
        },
        {
          "id": 74092,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Decreases Aqueous Production</span></span></span></span></p>"
        },
        {
          "id": 74093,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Increases Uveoscleral Outflow</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a mechanism through which Netarsudil acts?</span></span></span></p>",
      "unique_key": "Q7464279",
      "question_audio": null,
      "question_video": null,
      "map_id": 31275,
      "difficulty_level": "difficult",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) I<span style=\"color:black\">ncreases Uveoscleral Outflow</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Netarsudil does not significantly increase uveoscleral outflow. <strong>Prostaglandin analogues</strong> act by <strong>reducing uveoscleral outflow</strong>. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Netarsudil&nbsp;</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">is an <strong>inhibitor&nbsp;</strong>of <strong>both ROCK</strong> and the <strong>norepinephrine transporter</strong>. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">It is thought to <strong>work</strong> via <strong>3 mechanisms</strong>:</span></span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>trabecular outflow</strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduction&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>episcleral venous pressure</strong> by <strong>ROCK inhibition</strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduction&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">of <strong>aqueous production</strong> by <strong>norepinephrine transporter inhibition</strong></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increasing trabecular outflow&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">facilitates the <strong>outflow&nbsp;</strong>of <strong>aqueous humor</strong> through the <strong>trabecular meshwork pathway</strong>, thereby <strong>lowering intraocular pressure</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By <strong>inhibiting Rho kinase</strong>, <strong>Netarsudil</strong> can also lead to a <strong>decrease</strong> in <strong>episcleral venous pressure</strong>, contributing to its <strong>pressure-lowering effect</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreasing aqueous production</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Although not its primary mechanism, <strong>Netarsudil</strong> may <strong>slightly reduce</strong> the <strong>production</strong> of <strong>aqueous humor</strong>, further <strong>aiding</strong> in the <strong>reduction</strong> of <strong>intraocular pressure</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Netarsudil <strong>lowers intraocular pressure</strong> primarily by <strong>increasing trabecular outflow</strong> and <strong>decreasing episcleral venous pressure</strong>, but it does not significantly increase uveoscleral outflow.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: AAO Section: 2 &ndash; 2020 Edition Page 396; Kaufman AR, Elhusseiny AM, Edward DP, Vajaranant TS, Aref AA, Abbasian J. Topical Netarsudil for treatment of Glaucoma with Elevated Episcleral Venous Pressure: A Pilot investigation in Sturge-Weber Syndrome. Eur J Ophthalmol. 2023 Sep; 33(5):1969-1976. doi: 10.1177/11206721231159694. Epub 2023 Feb 27. PMID: 36850063.</span></strong></span></span></p>",
      "correct_choice_id": 74093,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}